Biographical Sketch
A native of South Carolina, Susan LeGrand, MD, joined Cleveland Clinic's pioneering Palliative Medicine program in 1998. Prior to this, she had a solo oncology practice in North Carolina. She received her undergraduate and medical education at the University of South Carolina, graduating cum laude and Phi Beta Kappa. She received the Behavioral Sciences Award in her first year of medical school. Dr. LeGrand is board-certified in internal medicine, medical oncology and hospice and palliative medicine. She was elected a Fellow of the American College of Physicians in 2002.
Dr. LeGrand has been a leader in palliative medicine fellowship education, co-chairing a workgroup to develop standards for fellowship training. She spearheaded the development of a Forum for Program Directors under the auspices of the American Academy of Hospice and Palliative Medicine and chaired that group through its infancy. She is a Master Facilitator for the Education in Palliative and End of Life Care program and was the palliative medicine representative on the Robert Wood Johnson Workgroup to improve end-of-life care for amyotrophic lateral sclerosis.
Dr. LeGrand is a frequent guest lecturer and presenter at national and international meetings on subjects related to palliative medicine and supportive care in cancer. She has authored or co-authored numerous articles and chapters on these topics.
Specialty Interests
palliative medicine, breast cancer, myeloma
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 8/2/2008, Dr.
LeGrand has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. LeGrand receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Medtronic, Inc.
